The present invention discloses thioflavine S and primuline derivatives which inhibit hepatitis C virus helicase and protease activity. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are useful as antiviral agents. The present invention further relates to pharmaceutical compositions containing the aforementioned compounds and methods of treating an HCV infection.
本发明揭示了
硫黄
荧光素S和初黄素衍
生物,其抑制丙型肝炎病毒的解旋酶和
蛋白酶活性。因此,本发明的化合物干扰了丙型肝炎病毒的生命周期,并可用作抗病毒剂。本发明还涉及含有上述化合物的制药组合物和治疗HCV感染的方法。